EIF3C and breast carcinoma: Deregulated EIF3C and EIF3D suppressed proliferation and promoted apoptosis in breast cancer, indicating that EIF3C and EIF3D act as oncogenes in breast cancer [56], whereas our findings showed that EIF3C and EIF3D were downregulated in breast cancer and that high expression of EIF3C and EIF3D was negatively related to worse outcomes in various types of breast cancer.